{"filing":{"accession_number":"0001104659-26-080617","cik":"0002124403","ticker":null,"company_name":"Vicore Pharma Holding AB","form":"6-K","filing_date":"2026-07-06","report_date":null,"primary_document":"tm2619347d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2124403/000110465926080617/tm2619347d1_6k.htm"},"events":[{"id":16168,"run_id":14426,"accession_number":"0001104659-26-080617","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The exhibit announces the appointment of Rob Slack, PhD, as Chief Scientific Officer of Vicore Pharma, effective immediately. This is a material executive appointment at a clinical-stage biopharmaceutical company, where the Chief Scientific Officer role is critical to research strategy and pipeline development. The disclosure also notes that the prior CSO, Johan Raud, is transitioning to Senior Advisor, which is a secondary departure element but the primary disclosed action is Slack's appointment to the CSO position.","company_name":"Vicore Pharma Holding AB","ticker":null,"filing_date":"2026-07-06","form":"6-K","submitted_at":null,"items":[{"id":14191,"accession_number":"0001104659-26-080617","item_number":"EX-99.1","item_title":"tm2619347d1_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces the appointment of Rob Slack, PhD, as Chief Scientific Officer of Vicore Pharma, effective immediately. This is a material executive appointment at a clinical-stage biopharmaceutical company, where the Chief Scientific Officer role is critical to research strategy and pipeline development. The disclosure also notes that the prior CSO, Johan Raud, is transitioning to Senior Advisor, which is a secondary departure element but the primary disclosed action is Slack's appointment to the CSO position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T13:17:37.668876+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14191,"accession_number":"0001104659-26-080617","item_number":"EX-99.1","item_title":"tm2619347d1_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces the appointment of Rob Slack, PhD, as Chief Scientific Officer of Vicore Pharma, effective immediately. This is a material executive appointment at a clinical-stage biopharmaceutical company, where the Chief Scientific Officer role is critical to research strategy and pipeline development. The disclosure also notes that the prior CSO, Johan Raud, is transitioning to Senior Advisor, which is a secondary departure element but the primary disclosed action is Slack's appointment to the CSO position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T13:17:37.668876+00:00","company_name":"Vicore Pharma Holding AB","ticker":null,"filing_date":"2026-07-06"}]}